Journal of Diabetes Research / 2017 / Article / Tab 4

Review Article

Classification and Differential Diagnosis of Diabetic Nephropathy

Table 4

Literature review of NDRD in China.

AuthorYear of publicationReferencesNumber of patients Pathological diagnosisStatistical analysis of NDRD (alone and coexistent with DN)
DNNDRDDN plus NDRD

Mak et al.1997[35]51671617IgAN (59%), HTN (24%)

Wong et al.2002[36]68354619IgAN (29.5%), HTN (20.4%), MN (18.2%), MCD (9%)

Cao et al.2007[37]12085.814.2IgAN (41.2%), MN (17.6%), HTN (11.7%), TIN (11.7%), RA (5.9%), FSGS (5.9%), micropolyarteritis (5.9%)

Zhou et al.2008[38]11054.545.5IgAN (34%), MN (22%), MPGN (14%), HBV-associated GN (8%), MCD (4%), HTN (4%), MPGN (4%), CrGN (2%)

Lin et al.2009[39]50482230MN (19.23%), IgAN (11.54%), MCD (3.85%), HTN (3.85%), ATN (3.85%), CIN (7.69%)

Mou et al.2010[40]6947.852.2FSGS (37.7%), IgAN (15.9%), MCD (15.9%), MN (8.7%)

Bi et al.2011[41]22054.545.5IgAN (34%), MN (22%), MPGN (14%), HBV-associated GN (8%), MCD (4%), HTN (4%), MPGN (4%), CrGN (2%)

Zhang et al.2011[42]13073.926.1IgAN (16.9%), MN (6.15%)

Zhuo et al.2013[43]2166.582.910.717–35 years (group I): IgAN (29%), MN (11.8%), FSGS (8.8%), MPGN (8.8%), APGN (5.9%), CrGN (5.9%); 36–59 years (group II): IgAN (34.7%), MN (15%), FSGS (1.4%), MPGN (6.1%), APGN (0.7%), CrGN (1.4%); 60 years (group III): IgAN (2.9%), FSGS (2.9%), MN (25.7%), CrGN (8.6%), MPGN (11.4%), RA (5.7%)

Peng and Wang2013[44]6152.547.5IgAN (31%), MN (17.2%), MPGN (13.8%), HTN (13.8%), FSGS (10.3%), MCD (6.9%), APGN (3.5%)

Wang2015[45]5657.142.9IgAN (33.3%), MN (25.0%), MPGN (20.8%), HTN (8.3%), FSGS (4.2%), MCD (4.2%)

Note. IgAN, primary IgA nephropathy; HTN, hypertensive nephrosclerosis; MN, membranous nephropathy; MCD, minimal change disease; TIN, tubulointerstitial nephritis; RA, renal amyloidosis; MPGN, mesangial proliferative glomerulonephritis; CrGN, crescentic glomerulonephritis; ATN, acute tubular necrosis; CIN, chronic interstitial nephritis; FSGS, focal segmental glomerular sclerosis.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.